Oxford Index Search Results

You are looking at 61-80 of 356 items for:

fusion x Medical Oncology x clear all

EXTH-04. TARGETING CD97 BY NOVEL FUSION PROTEIN DAF-FC INHIBITS GBM INVASION AND INDUCES ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY

Alan Nguyen, Michael Safaee, Ankush Chandra, Keith Wycoff and Manish Aghi.

in Neuro-Oncology

November 2018; p ublished online November 2018 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Abstract

INTRODUCTION

The poor prognosis of GBM reflects its capacity to supplement proliferative programs with...

NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: Results from single-cell cDNA analysis

L. Trümper, H. Daus, H. Merz, F. von Bonin, U. Loftin, C. Cochlovius, P. Möller, A. C. Feller and M. Pfreundschuh.

in Annals of Oncology

January 1997; p ublished online January 1997 .

Journal Article. Subjects: Medical Oncology. 0 words.

Summary

Background The translocation t(2;5)(p23;q35) leads to the fusion of the nucleophosmin gene (NPM) on chromosome 5q35 to the recently...

Go to »  abstract

A Case Report of Epithelioid Inflammatory Myofibroblastic Sarcoma with RANBP2-ALK Fusion Gene Treated with the ALK Inhibitor, Crizotinib

Shiro Kimbara, Koji Takeda, Hiroko Fukushima, Toru Inoue, Hideaki Okada, Yumi Shibata, Utae Katsushima, Asuka Tsuya, Shinya Tokunaga, Haruko Daga, Takahiro Okuno and Takeshi Inoue.

in Japanese Journal of Clinical Oncology

September 2014; p ublished online July 2014 .

Journal Article. Subjects: Clinical Medicine; Medical Oncology; Radiation Oncology; Surgical Oncology. 1801 words.

Epithelioid inflammatory myofibroblastic sarcoma is a variant of inflammatory myofibroblastic tumor with aggressive clinical course associated with RANBP2-ALK fusion. The present report...

Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions

M. Minhaj Siddiqui, Arvin K. George, Rachel Rubin, Soroush Rais-Bahrami, Howard L. Parnes, Maria J. Merino, Richard M. Simon, Baris Turkbey, Peter L. Choyke, Bradford J. Wood and Peter A. Pinto.

in JNCI: Journal of the National Cancer Institute

P ublished online April 2016 .

Journal Article. Subjects: Medical Oncology; Radiation Oncology; Surgical Oncology. 4594 words.

Background: Use of magnetic resonance (MR) imaging to improve prostate biopsy efficiency is rapidly gaining in popularity. The aim of this study was to assess the biopsy...

The product of the t(ll;18), an API2-MLT fusion, is an almost exclusive finding in marginal zone cell lymphoma of extranodal MALT-type

B. Maes, M. Baens, P. Marynen and Ch. De Wolf-Peeters.

in Annals of Oncology

May 2000; p ublished online May 2000 .

Journal Article. Subjects: Medical Oncology. 0 words.

Background: Extranodal marginal zone cell lymphoma (MZCL) of MALT-type share similar features with nodal and splenic MZCL regarding morphology and immunopheno-type. At the...

Go to »  abstract

LGG-57. FUNCTIONAL CHARACTERIZATION AND EFFECTIVE TARGETING OF NRF1-BRAF AND ATG7-RAF1 FUSIONS IDENTIFIED IN ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA PATIENTS WITHOUT BRAF p.V600E MUTATION

Poonam Sonawane, Patrick Diviney, Joanna Phillips, Payal Jain, Phillip Storm, Adam Resnick and Angela Waanders.

in Neuro-Oncology

June 2018; p ublished online June 2018 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Abstract

Pleomorphic xanthoastrocytoma (PXA) is a type of astrocytic glial neoplasm classified as WHO grade II and anaplastic PXA as WHO grade III. These...

Clinicopathological and Prognostic Relevance of Uptake Level using 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) in Primary Breast Cancer

Shigeto Ueda, Hitoshi Tsuda, Hideki Asakawa, Takashi Shigekawa, Kazuhiko Fukatsu, Nobuo Kondo, Mikio Yamamoto, Yukihiro Hama, Katsumi Tamura, Jiro Ishida, Yoshiyuki Abe and Hidetaka Mochizuki.

in Japanese Journal of Clinical Oncology

April 2008; p ublished online April 2008 .

Journal Article. Subjects: Medical Oncology. 4962 words.

Objective

Using integrated 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT), the clinical significance...

Go to »  abstract

LGG-46. TRAMETINIB THERAPY IN PEDIATRIC PATIENTS WITH LOW-GRADE GLIOMAS (LGG) WITH BRAF GENE FUSION; A DISEASE-SPECIFIC COHORT IN THE FIRST PEDIATRIC TESTING OF TRAMETINIB

Eric Bouffet, Mark Kieran, Darren Hargrave, Stephen Roberts, Isabelle Aerts, Alberto Broniscer, Birgit Geoerger, Kohinoor Dasgupta, Lillian Tseng, Mark Russo, Bijoyesh Mookerjee and Christopher Moertel.

in Neuro-Oncology

June 2018; p ublished online June 2018 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Abstract

BACKGROUND

LGG is the most prevalent childhood brain tumor. BRAF fusions drive constitutive activation of...

Fusion PET–CT imaging of neurolymphomatosis

A. Trojan, M. Jermann, C. Taverna and T. F. Hany.

in Annals of Oncology

May 2002; p ublished online May 2002 .

Journal Article. Subjects: Medical Oncology. 1943 words.

In a patient suffering from peripheral neuropathy due to neurolymphomatosis, fused PET–CT imaging, performed on a novel in-line PET–CT system, showed multiple small nodular lesions extending...

Go to »  abstract

RET-fusions: a novel paradigm in colorectal cancer

C Santos, R Sanz-Pamplona and R Salazar.

in Annals of Oncology

June 2018; p ublished online April 2018 .

Journal Article. Subjects: Medical Oncology. 1773 words.

ATIM-16. PHASE 1 STUDY RESULTS OF M7824 (MSB0011359C), A BIFUNCTIONAL FUSION PROTEIN TARGETING TGF- AND PD-L1, AMONG PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM)

Mustafa Khasraw, Michael Weller, David Lorente Estelles, Kathryn Kolibaba, Chee Lee, Craig Gedye, Macarena De La Fuente, David Vicente, David Reardon, Laureen Ojalvo, Christoph Helwig, Carole Gourmelon and Morris Groves.

in Neuro-Oncology

November 2018; p ublished online November 2018 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

Abstract

BACKGROUND

TGF- signaling promotes tumor immunosuppression; TGF- inhibition in the tumor microenvironment...

40The landscape of kinase fusions in 445 Chinese NSCLC patients

M W Chen, H Chen, M H Wang, T Shou, Y F Shi, Q S Guo, Y H Shang, J Hu, C Liu, L Dai, P Zhang, G W Chirn, K Wang and M Yao.

in Annals of Oncology

October 2017; p ublished online October 2017 .

Journal Article. Subjects: Medical Oncology. 296 words.

Cell Fusion Theory: Can It Explain What Triggers Metastasis?

Andrea Carter.

in JNCI: Journal of the National Cancer Institute

September 2008; p ublished online September 2008 .

Journal Article. Subjects: Medical Oncology. 1217 words.

A Novel Fusion Gene, SYT-SSX4, in Synovial Sarcoma

Bjorn Skytting, Gunnar Nilsson, Bertha Brodin, Yuntao Xie, Joakim Lundeberg, Mathias Uhlén and Olle Larsson.

in JNCI: Journal of the National Cancer Institute

June 1999; p ublished online June 1999 .

Journal Article. Subjects: Medical Oncology. 1021 words.

Stopping HIV fusion with enfuvirtide: the first step to extracellular HAART

Graeme Moyle.

in Journal of Antimicrobial Chemotherapy

February 2003; p ublished online February 2003 .

Journal Article. Subjects: Medical Oncology; Critical Care. 2662 words.

Go to »  abstract

L02.04AMP-224, A FUSION PROTEIN THAT TARGETS PD-1

F. Smothers, A. Hoos, S. Langermann, S. Marshall, R. May and M. Fleming.

in Annals of Oncology

March 2013; p ublished online March 2013 .

Journal Article. Subjects: Medical Oncology. 324 words.

Go to »  abstract

455PDifferential crizotinib response duration among ALK fusion variants in ALK-positive NSCLC

T. Yoshida, Y. Oya, K. Tanaka, J. Shimizu, Y. Horio, T. Hida and Y. Yatabe.

in Annals of Oncology

December 2015; p ublished online December 2015 .

Journal Article. Subjects: Medical Oncology. 301 words.

29PThe routine detection of ROS1 fusion rearrangement in non-small cell lung cancer

J. Wu, Y. Lin, X. He, P. He, X. Fu and X. Gu.

in Annals of Oncology

December 2015; p ublished online December 2015 .

Journal Article. Subjects: Medical Oncology. 374 words.

Small cell lung carcinoma harbors targetable alterations including MYCL1 fusions responding to aurora kinase inhibitor

S. Ali, B. Kolla, M. Bailey, A.B. Schrock, S.J. Klempner, G.M. Frampton, D.A. Fabrizio, S-H.I. Ou, J. He, J. Suh, J.S. Ross, P. Stephens, V. Miller and M. Patel.

in Annals of Oncology

October 2016; p ublished online October 2016 .

Journal Article. Subjects: Medical Oncology. 353 words.

O-020Activity of larotrectinib in patients with TRK fusion GI malignancies

M Nathenson, G Demetri, U Lassen, D Hong, V Boni, J Deeken, A Dowlati, M Cox, N Ku, S Cruickshank, H Qamoos and A Drilon.

in Annals of Oncology

June 2018; p ublished online June 2018 .

Journal Article. Subjects: Medical Oncology. 386 words.